current issue  |  archives  |  contact us    
               Download PDF   

  www.mediligence.com    
       may 2006 / volume 5, issue 5

Biotechnology Update:

Looking Deeper into the Heart with Multidetector CT

Spotlight on Heart Attacks

According to the American Heart Association, this year an estimated 1.2 million Americans will have a new or recurrent coronary attack, 700,000 will have a new coronary attack, and about 500,000 will have a recurrent attack. It is also estimated that an additional 175,000 silent first heart attacks occur each year while the incidence of myocardial infarction is 565,000 new attacks and 300,000 recurrent attacks annually. Presently, 13.2 million Americans have a history of heart attack, angina pectoris or both (7.2 million males and 6 million females). About 330,000 people per year die of coronary attack either in a hospital emergency department or without hospitalization. Most of these are sudden deaths caused by cardiac arrest, usually resulting from ventricular fibrillation.

Doctors from the departments of cardiology and radiology at Rambam Medical Center in Haifa, Israel, are using multidetector computed tomography (CT) to predict myocardial recovery after acute myocardial infarction. A study on the research was reported at the American Roentgen Ray Society annual meeting this month. Multidetector CT is lauded for its ability to image the coronary arterial tree, which is useful in patients with stable angina or those with chest pains who present at emergency departments unsure if their symptoms are actually heart related. However, based on these findings, this technology could also provide valuable prediction of future myocardial viability.

Instead of simply viewing patients’ coronary arteries on CT, the clinicians in this study also examined the myocardium for functional abnormalities if coronary stenosis was detected. This was achieved by analyzing the contrast enhancement of the myocardium.

Consecutive gated 16-slice CT coronary angiography was performed on 34 patients, all of whom had echocardiography examinations upon initiation and at follow-up. The researchers sought to view the heart muscle at the time of the patient’s heart attack and then compare this to the muscle’s functional recovery on the follow-up echocardiogram two to four months later. Myocardial-perfusion defects were detected in 24 of these patients and 8 showed no defects with the multidetector CT. Regions of the heart muscle that had reduced blood flow resulting from heart attack appeared as dark spots on the CT. During the follow-up echocardiograms, 7 of the 8 patients with no defects at baseline had completely recovered, while only 12 of the 24 patients with myocardial-perfusion defects had recovered.

When the physicians in this study performed the CT coronary angiography on each patient, they expanded their analysis beyond the normal criteria to also include coloration, density, and enhancement of the myocardium. The advantage to the technique used by the physicians is that it did not require an additional scan or put the patients through any additional radiation exposure. This significantly amplifies the future use of cardiac multidetector CT, and also equates to cost efficiencies from minimizing the use of additional radiation. The physicians concluded that cardiac multidetector CT was able to efficiently predict which patients would have reduced myocardial viability on follow-up echocardiography.

Cardiac CT machines are evolving rapidly, with scanners capable of ever-increasing slices, ranging from 64- to 256-slice scanners either available or being developed. However, larger number of slices will not provide an advantage for the purpose of detecting myocardial viability after heart attack because the dark spots are very visible and easy to detect on the 16-slice scans. In addition, multidetector CT scans have a distinct advantage over the standard angiography, which misses the vessel wall or the myocardium.

 
  © 2006 MedMarket Diligence, LLC. All Rights Reserved